How does the FDA regulate PRP marketing for doctors? Not the way most people think. The FDA does not approve PRP, and it does not regulate how a physician practices medicine. It regulates the device that prepares the PRP and what gets said about it, and the FTC and your state board read the rest of the ad.
TLDR: The FDA does not approve PRP. It clears the device that prepares it, for a stated use, and anyone can look that use up. So PRP marketing for doctors gets read in three layers: the FDA on the device, the FTC on the claims, and your state board on physician advertising. The words approved and cleared don’t belong on the PRP itself, and softer words like may or helps don’t fix a claim with no evidence behind it.
Important Note
This article is for educational purposes only and does not constitute legal, medical, or regulatory advice. Marketing strategies discussed should be reviewed by qualified legal counsel before implementation, particularly regarding FDA, FTC, and state-specific advertising regulations. Regen Portal is a marketing and consulting company, not a law firm. Nothing here implies FDA approval of any product or any use. Most cell, tissue and exosome products marketed to patients are not FDA approved, and the few cell-based products the FDA has approved are approved only for specific labeled indications. Nothing here promises a marketing or business outcome. Regulations change and enforcement varies by state. Confirm current requirements with qualified legal and compliance counsel before you act on anything you read here.
One thing that I see: reps routinely say things to clinic owners that aren’t FDA compliant. And that’s normal in this industry. Then I watch those same words travel from the rep’s pitch into the clinic’s own ads and marketing materials.
I know that pitch. I started in medical sales, and I’ve worked with PRP since 2016.
So how does the FDA regulate PRP marketing for doctors? The honest answer surprises people. I’m going to show you the three layers that read your ad and what each one looks for. The rest goes to your counsel.
Who Regulates PRP Marketing for Doctors? The Short Answer
Three layers do, and the FDA is only one of them. The FDA looks at the product and the device. The FTC looks at whether the ad is true and backed up, and your state board looks at how a physician advertises.
The surprise is where the FDA’s piece sits. Does the FDA approve PRP? No.
Does it regulate how a physician practices medicine? No. So what does it regulate? The device that prepares the PRP, and what gets said about that device and its uses.
Here’s how the three layers line up.
| Layer | What It Covers | What It Looks At |
|---|---|---|
| The FDA | Product and device status | What the device was cleared for, and what you say about it |
| The FTC | The ad itself | Whether each claim is true and backed by evidence |
| Your state board | The physician’s license | How a physician advertises in that state |
What this means for your practice: One sentence in an ad can get past one layer and still fail the next.
So here’s how I’d read PRP marketing for doctors. Every sentence, three times. Once for each layer. Who’s looking at this line, and what are they looking for?
What PRP Is in the FDA’s Rules
PRP is platelets and plasma concentrated from the patient’s own blood. In the federal tissue rules, blood components sit outside the definition of an HCT/P, which is a human cell or tissue product. So 361 and 351 are the wrong labels for PRP.
Why are they the wrong labels? Well, first of all, what’s a 361 product? It’s shorthand for an HCT/P that is regulated solely under section 361. And 351 is the label people use for one regulated as a drug or biological product.
The definitions are in 21 CFR 1271.3. The rule defines HCT/Ps as articles “containing or consisting of human cells or tissues” that are intended to go into a human recipient. Then it lists what is not an HCT/P.
Whole blood is on that list. Blood components are on that list. And PRP starts as blood, the patient’s own.
So 361 versus 351 is the wrong question for PRP. Counsel confirms how this applies to a specific preparation.
PRP also contains no stem cells. So the legal question for stem cells, which starts with the product’s FDA pathway, is a different conversation. The same goes for the minimally manipulated test. That test classifies an HCT/P, and the rule doesn’t treat a blood component as one.
What the FDA Actually Cleared: The Device
The FDA cleared the device that prepares the PRP. It did not clear or approve the PRP itself. And the device is cleared for a stated use, which you can look up yourself.
Let’s say a rep tells you the system is FDA cleared. It may well be. Cleared for what?
Go read the FDA’s platelet and plasma separator classification. The device name is “platelet and plasma separator for bone graft handling.” It’s a Class 2 device, and the submission type is 510(k). That’s the notice a device maker sends the FDA before marketing a device.
Now read the definition on that page. It describes preparing autologous platelet rich plasma, meaning the patient’s own, “from a small sample of peripheral blood for mixing with bone graft to improve handling characteristics.”
Bone graft handling. That’s the cleared use for that class of PRP systems. Joints, hair, skin? Those uses are off-label practice of medicine.
How do you check your own system? The FDA’s 510(k) clearances page, current as of May 29, 2024, links to a searchable database. Anyone can look up a device there and read what it was cleared for.
And cleared is not approved. The FDA has a consumer page on what FDA approval means, and it says a moderate-risk device may be marketed through 510(k) clearance. The maker has to show the device is “substantially equivalent to a legally marketed predicate device.”
I’d do that lookup before the purchase. Regulatory fit is the first step when you add a regenerative service line, and marketing is the last.
Why “FDA Approved PRP” Is Not a True Sentence
Because the FDA doesn’t approve PRP, and it doesn’t clear PRP either. So “FDA approved PRP” and “FDA cleared PRP” are both wrong. The clearance belongs to the device, and only for its stated use.
So how do those words end up on a clinic’s site? They travel. Let’s say the rep says cleared, and he means the system. Somebody at the clinic writes it down as cleared PRP, and by the time it’s a headline, cleared has turned into approved.
The superlatives travel too. I’ve watched the “best thing since sliced bread” kind of line go from a rep’s pitch to the clinic’s patients and its network.
The best system on the market? According to who?
Then there’s the credential version. Of all the credential claims on regen sites, “FDA registered clinic” is the one I see most. It’s everywhere.
That same FDA consumer page is current as of May 4, 2026. It says the FDA “does not ‘approve’ health care providers, including physician offices or laboratories.” And it says registration or listing “does not denote approval of the establishment.”
Registered is not approved. Cleared is not approved. That’s why the rules for biologics reps cover registered versus approved, and superlatives too.
What the FTC Asks of PRP Marketing for Doctors
The FTC asks two things of every ad. Is it true, and can you back it up? That goes for PRP too, because the FTC says its advertising law “applies to all products and claims.”
The detail is in the FTC’s health products compliance guidance, published in December 2022. It says health claims need “competent and reliable scientific evidence.” And for a health benefit, it says that generally means “randomized, controlled human clinical testing.”
So I ask the same question about every line. What’s the evidence for this sentence?
When we put that to a practice or a vendor, what comes back is usually vendor materials. Sometimes it’s a public clinical trial. And often it’s not much at all.
That’s a problem, because a reputation for safety rests on proof, not promises. And softer words don’t fix it. The guidance says “Vague qualifying terms are inadequate,” and it names “may” and “helps” as its examples.
The FTC also reads the whole ad at once. It calls that the net impression, which is the text, the product name and the images together. And it says a marketer is “equally responsible” for claims that are suggested or implied.
And who answers for the rep’s line once it’s in your ad? The guidance says “All parties who participate directly in marketing and promotion” have an obligation here. Each one has to see that claims are presented truthfully, and has to check that the support for those claims is adequate. So it’s your claim now.
Where Your State Board Comes In
Your state board is the third layer, and it’s the one that holds the physician’s license. It looks at how a physician advertises. The rules differ by state, and so this layer goes to your counsel.
Going back to the FDA for a second. It regulates the device. How a physician uses PRP for a patient is the practice of medicine, and that sits with the state.
So does off-label mean anything goes in PRP marketing for doctors? No. The use is the physician’s call. The ad is still an ad, and all three layers read it.
I won’t tell you what your board allows. Here’s what I’d bring to counsel:
- What does my board say about how a physician advertises?
- Does it have rules on patient testimonials or photos?
- How may I describe my training and my specialty?
- Who signs off on an ad before it goes live?
State law never overrides federal law. It sits on top of it. And the ad platforms add rules of their own, so PRP ads on Facebook are their own question.
Picture a Practice That Just Bought a PRP System
Picture a practice where two physicians share one suite and one billing manager. It bought its first PRP system six weeks ago. Nobody on staff has marketing in the job title, and so the billing manager wrote the new web page from the rep’s brochure. This scenario is illustrative and does not describe any Regen Portal client.
The Challenge: The brochure says the system is FDA cleared. The new headline says the PRP is cleared, which is not a true sentence. Two lines down, a superlative from the rep’s pitch sits next to a claim about joints.
The Approach: One of the physicians reads the page three times, once for each layer. The device comes first, and so that physician looks it up in the FDA’s 510(k) database. Then each claim gets the evidence question, and the board question goes to counsel.
The Compliance Check: The status line gets rewritten to describe the device and its cleared use. It also says plainly that any other use is off-label. The superlative comes out, and so does any claim with no evidence behind it. Counsel reads the page against the state’s physician advertising rules.
What Changed: The page now says what PRP is, in plain words. The front desk knows what to say when someone asks if it’s FDA approved. And when a rep’s line shows up in the next draft, the billing manager asks where it came from.
Frequently Asked Questions
Is PRP FDA Approved?
No. The FDA does not approve PRP, which is prepared from the patient’s own blood. What the FDA clears is the device that prepares it, for a stated use. So I’d keep the words approved and cleared off the PRP itself, on every page and in every ad.
Is PRP a 361 Product?
No. That label belongs to certain human cell and tissue products, called HCT/Ps. The federal tissue rules leave blood components out of the HCT/P definition, and PRP is prepared from the patient’s own blood. Counsel confirms how this applies to a specific preparation.
Can I Say My PRP System Is FDA Cleared?
Only what the clearance itself says. Look your device up in the FDA’s 510(k) database and read what it was cleared for. Then keep the sentence about the device and that use. A device clearance does not carry over to joints, hair, skin or anything else, and counsel should see the final wording.
Does the FDA Regulate Off-Label Use of PRP?
Not the use itself. The FDA regulates the device and what gets said about it. Using PRP outside the device’s cleared use is off-label practice of medicine, and that’s the physician’s call under state rules. The ad for that use still gets read by all three layers.
Can I Advertise PRP on Google?
Not to promote the treatment, under Google’s ads policy. The policy names platelet rich plasma among its examples of what ads may not promote. Its exception covers ads that are “exclusively educational or informational in nature,” and it’s narrow. Google’s own examples are academic papers and tickets for medical conferences, not a clinic’s page with a booking button.
Key Takeaways
- Three layers read PRP marketing for doctors: the FDA, the FTC and your state board.
- PRP is a blood component, and the tissue rules don’t treat blood components as HCT/Ps.
- The FDA clears the device that prepares PRP, for a stated use you can look up.
- The words approved and cleared don’t belong on the PRP itself.
- The FTC wants evidence for every claim, and softer words don’t fix it.
- A rep’s line becomes your claim once it’s in your ad.
- Your board’s rules differ by state, and counsel decides that part.
Your Next Step
Three layers read PRP marketing for doctors, and each one is looking for something different. So before a line goes live, I’d ask what each of the three would make of it. The FDA? The FTC? Your board?
A rep’s brochure, or a page your team built from one, is a good place to start. In a compliance review of PRP marketing, we read claims before anything else, because the exposure is highest there. Reviews and testimonials are next, then patient data, then a record of each decision and the reason for it.
PS: If there’s one line about PRP on your site with the word cleared or approved in it, that’s the line I’d read first. Reach out when you need help.
Email: hello@regenportal.com
YouTube: Subscribe to the channel
About Regen Portal
Regen Portal is a marketing and consulting company built for the regenerative medicine industry. We handle practice consulting, marketing compliance, search engine optimization, content creation, social media management, paid advertising, website development, branding, and AI and ops consulting for clinics, manufacturers, distributors, and independent providers. For more on me and how we work, visit Regen Portal and contact us.
About the Author
Oscar Tellez is the founder of Regen Portal, a marketing and consulting company built for the regenerative medicine industry. He has been in this industry since 2015. He started in medical sales and has worked with PRP since 2016. He has reached hundreds of practices and over 200 doctors through sales, teaching and marketing. He holds a B.S. in Exercise Science and Health Promotion from Florida Atlantic University.
